71 related articles for article (PubMed ID: 11463728)
1. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block.
Lupoglazoff JM; Cheav T; Baroudi G; Berthet M; Denjoy I; Cauchemez B; Extramiana F; Chahine M; Guicheney P
Circ Res; 2001 Jul; 89(2):E16-21. PubMed ID: 11463728
[TBL] [Abstract][Full Text] [Related]
2. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Base Editing of
Qi M; Ma S; Liu J; Liu X; Wei J; Lu WJ; Zhang S; Chang Y; Zhang Y; Zhong K; Yan Y; Zhu M; Song Y; Chen Y; Hao G; Wang J; Wang L; Lee AS; Chen X; Wang Y; Lan F
Circulation; 2024 Jan; 149(4):317-329. PubMed ID: 37965733
[TBL] [Abstract][Full Text] [Related]
4. Structures Illuminate Cardiac Ion Channel Functions in Health and in Long QT Syndrome.
Brewer KR; Kuenze G; Vanoye CG; George AL; Meiler J; Sanders CR
Front Pharmacol; 2020; 11():550. PubMed ID: 32431610
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of a human induced pluripotent stem cell line from a long QT syndrome patient harboring a heterozygous mutation of c.1537C > T in SCN5A gene.
Chen J; Song Y; Gu J; Chen L
Stem Cell Res; 2021 Dec; 57():102576. PubMed ID: 34678660
[TBL] [Abstract][Full Text] [Related]
6. Homozygous and compound-heterozygous mutations in TGDS cause Catel-Manzke syndrome.
Ehmke N; Caliebe A; Koenig R; Kant SG; Stark Z; Cormier-Daire V; Wieczorek D; Gillessen-Kaesbach G; Hoff K; Kawalia A; Thiele H; Altmüller J; Fischer-Zirnsak B; Knaus A; Zhu N; Heinrich V; Huber C; Harabula I; Spielmann M; Horn D; Kornak U; Hecht J; Krawitz PM; Nürnberg P; Siebert R; Manzke H; Mundlos S
Am J Hum Genet; 2014 Dec; 95(6):763-70. PubMed ID: 25480037
[TBL] [Abstract][Full Text] [Related]
7. In silico investigations on functional and haplotype tag SNPs associated with congenital long QT syndromes (LQTSs).
Sudandiradoss C; Sethumadhavan R
Genomic Med; 2008 Dec; 2(3-4):55-67. PubMed ID: 19214780
[TBL] [Abstract][Full Text] [Related]
8. Mexiletine infusion challenge test for neonatal long QT syndrome with 2:1 atrioventricular block.
Okuwaki H; Kato Y; Lin L; Nozaki Y; Takahashi-Igari M; Horigome H
J Arrhythm; 2019 Aug; 35(4):685-688. PubMed ID: 31410243
[TBL] [Abstract][Full Text] [Related]
9. Fins, fur, and wings: the study of Tmem161b across species, and what it tells us about its function in the heart.
Smith KA; Dominado N; Briffa JF
Mamm Genome; 2023 Jun; 34(2):270-275. PubMed ID: 37222785
[TBL] [Abstract][Full Text] [Related]
10. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
Kapplinger JD; Tester DJ; Salisbury BA; Carr JL; Harris-Kerr C; Pollevick GD; Wilde AA; Ackerman MJ
Heart Rhythm; 2009 Sep; 6(9):1297-303. PubMed ID: 19716085
[TBL] [Abstract][Full Text] [Related]
11. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
Tester DJ; Will ML; Haglund CM; Ackerman MJ
Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
[TBL] [Abstract][Full Text] [Related]
13. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.
Viswanathan PC; Benson DW; Balser JR
J Clin Invest; 2003 Feb; 111(3):341-6. PubMed ID: 12569159
[TBL] [Abstract][Full Text] [Related]
14. Long QT and Brugada syndrome gene mutations in New Zealand.
Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
[TBL] [Abstract][Full Text] [Related]
15. Paralogous annotation of disease-causing variants in long QT syndrome genes.
Ware JS; Walsh R; Cunningham F; Birney E; Cook SA
Hum Mutat; 2012 Aug; 33(8):1188-1191. PubMed ID: 22581653
[TBL] [Abstract][Full Text] [Related]
16. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.
McLaren W; Pritchard B; Rios D; Chen Y; Flicek P; Cunningham F
Bioinformatics; 2010 Aug; 26(16):2069-70. PubMed ID: 20562413
[TBL] [Abstract][Full Text] [Related]
17. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG).
Sinner MF; Pfeufer A; Akyol M; Beckmann BM; Hinterseer M; Wacker A; Perz S; Sauter W; Illig T; Näbauer M; Schmitt C; Wichmann HE; Schömig A; Steinbeck G; Meitinger T; Kääb S
Eur Heart J; 2008 Apr; 29(7):907-14. PubMed ID: 18222980
[TBL] [Abstract][Full Text] [Related]
18. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
Yang P; Kanki H; Drolet B; Yang T; Wei J; Viswanathan PC; Hohnloser SH; Shimizu W; Schwartz PJ; Stanton M; Murray KT; Norris K; George AL; Roden DM
Circulation; 2002 Apr; 105(16):1943-8. PubMed ID: 11997281
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
